Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child

Mohanad Shukry, Usha Ramadhyani

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Dexmedetomidine (Precedex™) is an α2 adrenoceptor agonist which is gaining popularity as a sedative and anesthetic adjuvant. In this case report, dexmedetomidine was used safely and easily to provide sedation for 12 radiation-therapy sessions in a pediatric patient. It provided smooth induction and fast recovery with minimal respiratory depression.

Original languageEnglish (US)
Pages (from-to)241-242
Number of pages2
JournalPaediatric Anaesthesia
Volume15
Issue number3
DOIs
StatePublished - 2005

Keywords

  • Dexmedetomidine
  • Radiation therapy
  • Sedation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child'. Together they form a unique fingerprint.

  • Cite this